Financial Results - Standalone (₹ in lakhs)

Quarter Ended June 30, 2026 (Unaudited):

  • Revenue from operations: ₹1,805.83
  • Other income: ₹645.77
  • Total income: ₹2,451.60
  • Total expenses: ₹1,587.08
  • Profit before tax and exceptional items: ₹864.52
  • Exceptional items: None
  • Profit before tax: ₹864.53
  • Tax expense: ₹140.65 (Provision for taxation: ₹125.00, Deferred tax: ₹15.64)
  • Net profit for the period: ₹723.88
  • Total comprehensive income: ₹723.88
  • Basic & diluted EPS: ₹12.93

Comparative Standalone Performance:

  • Q1 FY26 (June 30, 2025): Net profit ₹398.57, EPS ₹7.12
  • Q4 FY26 (March 31, 2026): Net profit ₹111.15, EPS ₹1.98
  • Full Year FY26: Net profit ₹871.38

Financial Results - Consolidated (₹ in lakhs)

Quarter Ended June 30, 2026 (Unaudited):

  • Revenue from operations: ₹1,812.89
  • Other income: ₹656.79
  • Total income: ₹2,469.68
  • Total expenses: ₹1,609.26
  • Profit before share of associate and exceptional items: ₹860.42
  • Share of profit from associate: ₹27.30
  • Exceptional items loss: ₹202.98
  • Profit before tax: ₹(135.43)
  • Tax benefit: ₹(78.40) (Provision for taxation: ₹(53.91), Earlier year tax written back: ₹(25.60), Deferred tax: ₹1.11)
  • Net loss for the period: ₹(57.03)
  • Total comprehensive loss: ₹(84.72)
  • Basic & diluted EPS: ₹(1.02)

Consolidated Entities:

  • Parent: Shri Dinesh Mills Limited
  • Subsidiaries: Fernway Technologies Limited, Stellent Chemicals Industries Limited
  • Step-down associate: McGean India Chemicals Private Limited (associate of Stellent Chemicals)

Subsidiary and Associate Details

  • Two subsidiaries (Fernway Technologies Limited and Stellent Chemicals Industries Limited) were not reviewed by their auditors
  • These unreviewed subsidiaries reported total revenues of ₹45.38 lakhs and net profit of ₹23.20 lakhs for the quarter
  • The Group's share of profit from associate (McGean India Chemicals) was ₹27.30 lakhs for the quarter
  • Dinesh Remedies Limited ceased to be a subsidiary effective September 3, 2025, and its results are reported under discontinued operations

Corporate Developments

Family Settlement Agreement (FSA):

  • Promoters executed a Family Settlement Agreement on April 29, 2026 between Shri Bharatbhai Patel & Shri Aditya Patel (BUP Family) and Shri Nimishbhai Patel & Shri Nishank Patel (NUP Family)
  • The Company was not a party to the FSA
  • Board noted the disclosure and granted in-principle approval for demerger of the Company's FELT business into a separate legal entity
  • Demerger subject to NCLT and other approvals
  • Until proposed demerger, Board approved segregation of FELT and Residual Businesses with assigned directors for separate oversight of each vertical

Notes to Financial Results

  • The company has only one reportable primary business segment: "Textiles"
  • Figures for quarter ended March 31, 2026 are balancing figures between audited full year and published unaudited YTD figures
  • Previous period figures have been regrouped/reclassified where necessary
  • Exceptional items represent adjustments related to Voluntary Retirement Scheme